Mechanical ventilation: recent advances in clinical practice and management

Mechanical ventilation has evolved significantly from its origins as a simple tool for gas exchange to a sophisticated, multi-organ protective therapy. While the 2000 ARDS Network trial established low tidal volume ventilation as the cornerstone of lung protection, contemporary practice now integrates a broader framework. This includes managing driving pressure, optimizing positive end-expiratory pressure (PEEP) based on individual lung recruitability, and utilizing noninvasive modalities like high-flow nasal cannula (HFNC) to delay or avoid invasive intubation. The current goal is to balance respiratory support with the preservation of hemodynamic, diaphragmatic, and neurocognitive function.

Modern management is moving away from population-based, fixed-parameter targets toward precision ventilation. Clinicians are increasingly using bedside tools—such as electrical impedance tomography (EIT) and esophageal pressure monitoring—to tailor settings to a patient's specific respiratory mechanics and biological phenotype. This shift is driven by the recognition that mechanical ventilation can trigger a cascade of complications, including ventilator-induced lung injury (VILI), ventilator-associated pneumonia (VAP), and intensive care unit-acquired weakness (ICUAW). By targeting individualized metrics like driving pressure and monitoring diaphragm function, clinicians can mitigate the risk of these interconnected, self-reinforcing complications.

Effective management of critically ill patients requires an integrated, bundle-based approach. This includes early mobilization, light sedation protocols, and standardized weaning trials to interrupt the vicious cycles of delirium, immobility, and muscle atrophy. While emerging technologies like AI-assisted decision support and closed-loop ventilation systems show promise in automating these complex adjustments, they currently face challenges regarding external validation and clinical interpretability. Consequently, the most effective strategy remains the combination of evidence-based protocols with interdisciplinary clinical oversight.